Monoclonal antibody 'cocktail' halts Zika infection

October 4, 2017, University of Miami Leonard M. Miller School of Medicine
Zika virus particles (red) shown in African green monkey kidney cells. Credit: NIAID

A collaborative study led by a University of Miami Miller School of Medicine researcher has found that a "cocktail" of monoclonal antibodies prevented Zika virus (ZIKV) infection in primates. "This is a promising intervention to prevent and treat ZIKV infection during pregnancy," said David Watkins, Ph.D., professor and vice chair for research, Department of Pathology. "We would like to develop this antibody combination and get it into clinical trials as soon as possible."

Watkins and Dennis Burton, Ph.D., chairman and professor of the Department of Immunology & Microbiology at the Scripps Research Institute, led the collaborative international study, "Neutralizing Human Monoclonal Antibodies Prevents Zika Virus Infection in Macaques," published recently in Science Translational Medicine. Miller School co-authors included Diogo M. Magnani, Ph.D., associate scientist and co-first author of the study; Ronald C. Desrosiers, Ph.D., professor of pathology and director of research faculty development; Michael J. Ricciardi, Varian K. Bailey, Lucas Gonzalez-Nieto, Martin J. Gutman, Núria Pedreño-Lopez, Helen S. Maxwell, Aline Domingues, and Mauricio A. Martins, Ph.D., all in the Department of Pathology.

"ZIKV infection is a serious, ongoing public health threat to South Florida, the Caribbean, Latin America and other regions around the world," Watkins said. "If a Zika outbreak occurs in a metropolitan area like Miami, the only way to prevent infection is to avoid the Aedes aegypti mosquitoes that carry the .

Therapies to prevent maternal Zika virus infection and its subsequent fetal developmental complications are urgently required."

Working closely with Burton and Tom Rogers, M.D., Ph.D., from the Scripps Research Institute in La Jolla, California, Watkins' laboratory team used a cocktail of three monoclonal antibodies to treat four monkeys. These three potent ZIKV-neutralizing - called SMZAb1, SMZAb2, and SMZAb5 - were isolated by the Burton group from a South American patient.

Infographic explaining the global prevalence of Zika virus. Credit: Carla Schaffer / AAAS

"We administered a cocktail of these three antibodies to nonhuman primates one day before challenging them with Zika virus that had been isolated from a pregnant woman during the 2016 epidemic in Rio de Janeiro," he said. "To our surprise, this prophylactic treatment completely prevented the virus from taking hold in the animals."

In four control animals, the virus caused a fulminant that lasted for seven days, Watkins added. But there were no measurable virus levels in the blood of the four animals treated with the monoclonal combination, nor was there any immune system response, indicating the virus had been blocked completely.

"Since these have exceptional safety profiles in humans and cross the placenta, this combination could be rapidly developed to protect uninfected pregnant women and their fetuses," he said.

Explore further: Prior dengue or yellow fever exposure does not worsen Zika infection in monkeys

More information: D.M. Magnani el al., "Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/ … scitranslmed.aan8184

Related Stories

Prior dengue or yellow fever exposure does not worsen Zika infection in monkeys

August 4, 2017
Rhesus macaques previously infected with dengue or yellow fever viruses appear to be neither more nor less susceptible to severe infection with Zika virus, according to new research published in PLOS Pathogens.

Early study finds antibody that 'neutralizes' Zika virus

November 7, 2016
Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis, Missouri, have isolated a human monoclonal antibody that in a mouse model "markedly reduced" infection by the ...

CDC shutters command center for Zika monitoring

October 3, 2017
With Zika waning in the Caribbean and South America, the Centers for Disease Control and Prevention announced on Friday that the federal agency was deactivating the command center for monitoring and coordinating emergency ...

Antibody protects against Zika and dengue, mouse study shows

September 25, 2017
Brazil and other areas hardest hit by the Zika virus - which can cause babies to be born with abnormally small heads - are also home to dengue virus, which is spread by the same mosquito species.

A human bi-specific antibody against Zika virus with high therapeutic potential

September 22, 2017
The journal Cell today published data with a bi-specific antibody against Zika virus infection. The article is titled "A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential."

Zika monkey study suggests worse fetal effects for vaginal versus mosquito transmission

August 24, 2017
Rhesus macaques that were vaginally infected with Zika virus showed higher prevalence of Zika in the reproductive tract than previously seen in macaques that received skin injections of the virus. The findings, published ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.